Live tape
Top 8, mentions 7d10,066TSLA2,067 mentions▲ +0.05GOOGL1,609 mentions▲ +0.04NVDA1,230 mentions▲ +0.07CRWV1,216 mentions▲ +0.03SPCX1,103 mentions▲ +0.07QQQ1,076 mentions▲ +0.04META891 mentions▲ +0.05NBIS874 mentions▲ +0.06

Equity · Healthcare

WVE

NASDAQ

Wave Life Sciences Ltd.

$5.82 +2.74% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close)
Price · Chart

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for WVE to draw a line in its place.

Track this symbol on TradingView TradingView chart
Market cap $1.1B
52-week range $5.65 – $21
Avg volume 768.7K

as of Jul 17, 2026

WVE insider trades

SEC Form 4 · last 90 days · newest Form 4 filing 5 Oct 2026
Open-market buys 0
Open-market sells 0
Non-trade filings 1

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
05 Oct 2026 RA CAPITAL MANAGEMENT, L.P. Director Award 10,700

WVE reported financials

SEC EDGAR XBRL SEC EDGAR

WVE reported revenue of $42.7M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$204.4M.

Figure Reported Period
Revenue $42.7M 31 Dec 2025 fiscal year
Net income −$204.4M 31 Dec 2025 fiscal year
Diluted EPS −$1.21 31 Dec 2025 fiscal year
Total assets $558.3M 30 Jun 2026 at period end
Total equity $453.5M 30 Jun 2026 at period end

WVE earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 −$0.34 —
31 Mar 2026 Q1 2026 −$0.13 —
31 Dec 2025 FY 2025 −$1.21 —
30 Sep 2025 Q3 2025 −$0.32 —
30 Jun 2025 Q2 2025 −$0.31 —
31 Mar 2025 Q1 2025 −$0.29 —
31 Dec 2024 FY 2024 −$0.70 —
30 Sep 2024 Q3 2024 −$0.47 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

WVE institutional holders

SEC Form 13F SEC EDGAR

12 of the 45 institutional funds we track reported a WVE position for the quarter ended 30 Jun 2026 — a combined $147.5M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Maverick Capital Held (±25%) +1.1% shares 10,278,115 $59.7M
Two Sigma Investments Added +97.4% shares 3,707,686 $21.5M
Millennium Management Added +86.3% shares 1,811,282 $10.5M
D. E. Shaw & Co. Added +2,351.0% shares 1,772,228 $10.3M
Renaissance Technologies Added +185.4% shares 1,704,520 $9.9M
AQR Capital Management Added +265.3% shares 1,648,045 $9.6M
Point72 Asset Management New position 1,484,989 $8.6M
Marshall Wace Trimmed −44.2% shares 999,533 $5.8M
Baker Bros. Advisors Held (±25%) 822,638 $4.8M
Man Group Added +689.3% shares 505,456 $2.9M

Showing the 10 largest of 12 reported positions. The figures above count all of them.

WVE fails-to-deliver

SEC CNS data SEC

On 23 Sep 2026, 1,660 shares of WVE failed to deliver (about $7K) — the latest of 3 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
23 Sep 2026 1,660 $7K 0.001%
22 Sep 2026 1,660 $7K 0.001%
21 Sep 2026 25,752 $112K 0.013%
08 Sep 2026 16 $78 <0.001%

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. SEC EDGARValuation computed from SEC EDGAR filings